NIH-funded research R01 grant

Reducing fracture risk in patients with Parkinson's disease

Official title: Prevention of Fractures in Patients with Parkinson's Disease

Funded at California Pacific Med Ctr Res Institute · NIH-10863965 · Data updated 2026-11-12

This study is looking at ways to help people with Parkinson's disease avoid fractures, since they often fall more and are at greater risk; it will test if vitamin D and other treatments can make a difference in keeping them healthy and safe.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCalifornia Pacific Med Ctr Res Institute
NIH-funded
Lab location1 site (San Francisco, United States)
Project startSeptember 30, 2018
Project endFebruary 28, 2026
Funding year2024
Award (this year)$3,135,800
NIH project number5R01AG059417-05
Project IDNIH-10863965 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals aged 65 or older with Parkinson's disease who are at high risk for fractures.

Less likely to help

Patients with Parkinson's disease who are younger than 65 or those without a significant risk of fractures may not benefit from this research.

What this research studies

This research investigates how to prevent fractures in patients with Parkinson's disease, who are at a significantly higher risk of fractures due to frequent falls. The study aims to address barriers that prevent these patients from receiving effective osteoporosis treatments, including lack of evidence for their effectiveness in this population and challenges related to medical visits and medication adherence. By conducting a randomized trial, the research will explore the impact of vitamin D supplementation and other interventions on fracture risk and overall health outcomes for these patients.

Why it matters

Potential benefit: If successful, this research could lead to improved fracture prevention strategies for patients with Parkinson's disease, enhancing their quality of life and reducing mortality associated with fractures.

How similar studies have gone: Previous research has shown that addressing barriers to osteoporosis treatment can improve outcomes, but this specific approach in Parkinson's disease is relatively novel.

Where this research is happening

  • California Pacific Med Ctr Res Institute
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Cummings, Steven Ron — California Pacific Med Ctr Res Institute
  • Study coordinator: Cummings, Steven Ron

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.